Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
11.28
|
12.73
|
13.00
|
11.25
|
13.00
|
11.59
|
|
|
182 436.34
|
234.00
|
13.01
|
13.78
|
13.65
|
13.43
|
13.65
|
13.50
|
|
|
14 552.78
|
74.00
|
13.00
|
14.80
|
14.80
|
13.30
|
14.81
|
13.50
|
|
|
51 933.88
|
135.00
|
11.00
|
16.17
|
15.91
|
13.50
|
15.91
|
14.36
|
|
|
103 934.20
|
163.00
|
15.47
|
16.59
|
16.42
|
15.39
|
17.42
|
15.39
|
|
|
159 911.36
|
195.00
|
14.92
|
17.00
|
16.66
|
15.00
|
16.66
|
16.00
|
|
|
70 969.67
|
97.00
|
15.00
|
17.15
|
16.55
|
16.18
|
17.15
|
17.15
|
|
|
33 380.19
|
90.00
|
16.28
|
17.37
|
15.99
|
15.94
|
17.25
|
16.86
|
|
|
71 663.55
|
151.00
|
15.16
|
16.15
|
15.25
|
14.69
|
15.50
|
15.40
|
|
|
54 647.57
|
149.00
|
14.29
|
16.00
|
14.20
|
14.20
|
15.88
|
14.61
|
|
|
286 473.40
|
391.00
|
Avalo Therapeutics Inc (formerly Cerecor Inc.) is a leading clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology, and rare genetic diseases.